The GABRG2 gene is associated with a form of epilepsy known as childhood absence epilepsy type 2, a condition characterized by frequent, brief loss of consciousness and staring spells. This condition often starts in childhood and can significantly impact an individual's quality of life. The GABRG2 gene plays a crucial role in the functioning of GABA receptors, which are involved in inhibiting nerve transmission in the brain, and mutations in this gene can disrupt this process, leading to seizures.
DNA Labs UAE offers a specialized genetic test to identify mutations in the GABRG2 gene, which can be instrumental in diagnosing childhood absence epilepsy type 2. This test is particularly valuable for families with a history of this condition, providing them with crucial information that can guide treatment and management strategies. The test is priced at 4400 AED and involves a simple procedure, typically requiring only a blood sample or cheek swab from the patient.
By identifying specific genetic mutations associated with epilepsy, this test enables healthcare providers to offer a more personalized approach to treatment, potentially improving outcomes for affected individuals. It also offers families the opportunity to understand their risk of passing the condition onto future generations, aiding in informed family planning decisions.
The GABRA1 gene plays a crucial role in the normal functioning of the brain. Mutations in this gene are associated with several forms of epilepsy, including Childhood Absence Epilepsy Type 4 (CAE4), a condition characterized by frequent absence seizures that begin in childhood. These seizures involve brief episodes of staring and unresponsiveness, significantly impacting the child's quality of life and cognitive development.
To identify susceptibility to CAE4, genetic testing for mutations in the GABRA1 gene is available. Conducted at DNA Labs UAE, this specialized test offers a comprehensive analysis of the GABRA1 gene to detect mutations that may predispose an individual to this form of epilepsy. The test is a critical tool for early diagnosis, allowing for timely intervention and management of the condition.
The cost of the GABRA1 gene epilepsy susceptibility test is 4400 AED. This investment covers the genetic analysis and the professional interpretation of results, providing valuable insights into the individual's genetic predisposition to CAE4. Early detection through this test can lead to better management strategies, potentially improving the quality of life for those affected by this condition.
The GABRB3 gene plays a crucial role in the development and function of the brain, particularly in the regulation of neurotransmission. Mutations in this gene have been linked to various neurological conditions, including Epilepsy Childhood Absence Type 5 (ECAT5). This specific type of epilepsy is characterized by frequent absence seizures that begin in childhood, significantly affecting attention and learning.
To diagnose and manage ECAT5 effectively, genetic testing for mutations in the GABRB3 gene is essential. DNA Labs UAE offers a comprehensive genetic test designed to identify mutations in the GABRB3 gene that are associated with Epilepsy Childhood Absence Type 5. This test is a valuable tool for clinicians in confirming the diagnosis, which can then guide treatment decisions and genetic counseling.
The cost of the GABRB3 gene epilepsy genetic test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the GABRB3 gene. The results of this test can provide crucial information for the effective management and treatment of individuals with ECAT5, offering them a better quality of life.
The CACNA1H gene plays a crucial role in the proper functioning of the body's cellular electrical signaling, which is essential for the normal operation of various physiological processes, including those in the brain. Mutations in the CACNA1H gene have been linked to epilepsy childhood absence type 6 (ECAT6), a specific form of epilepsy characterized by frequent, brief absence seizures that begin in childhood. These seizures involve short periods of staring and unresponsiveness, significantly impacting the child's quality of life and cognitive development.
To aid in the diagnosis and management of ECAT6, genetic testing for mutations in the CACNA1H gene is available. This test can confirm a diagnosis, help predict the course of the disease, and inform treatment decisions. Conducted at specialized facilities such as DNA Labs UAE, this genetic test involves analyzing the patient's DNA to identify mutations in the CACNA1H gene that are associated with the condition.
The cost of the CACNA1H gene epilepsy childhood absence type 6 susceptibility genetic test at DNA Labs UAE is 4400 AED. This price may reflect the comprehensive nature of the testing process, which includes the collection of a DNA sample, usually through a blood draw or cheek swab, followed by sophisticated genetic analysis in the laboratory. The result from this test not only helps in confirming the diagnosis but also plays a critical role in the personalized treatment planning, offering a targeted approach based on the individual's genetic makeup.
In summary, the CACNA1H gene epilepsy childhood absence type 6 susceptibility genetic test is a valuable diagnostic tool offered at DNA Labs UAE, with the potential to significantly impact the management and treatment of affected individuals by providing precise genetic insights into their condition.
The DEPDC5 gene plays a significant role in the development of familial focal epilepsy with variable foci, a complex form of epilepsy characterized by seizures originating in different parts of the brain. This condition is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the gene is sufficient to increase the risk of developing epilepsy.
DNA Labs UAE offers a specialized genetic test to identify mutations in the DEPDC5 gene, providing essential information for families affected by this condition. The test is crucial for accurate diagnosis, understanding the risk of transmission to offspring, and guiding treatment decisions. The cost of the test is 4400 AED, making it a valuable investment for families seeking insights into their genetic predisposition to familial focal epilepsy with variable foci. This test is a step forward in personalized medicine, allowing for tailored treatment plans based on genetic makeup.
The LGI1 Gene Epilepsy Familial Temporal Lobe Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the LGI1 gene that are associated with familial temporal lobe epilepsy type 1 (FTLE1). This condition is a form of epilepsy that typically affects families and is characterized by seizures originating in the temporal lobe of the brain. These seizures can manifest as sensory disturbances, emotional changes, or complex partial seizures that may progress to generalized tonic-clonic seizures.
The test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for specific genetic alterations in the LGI1 gene. Identifying mutations in this gene can confirm a diagnosis of FTLE1, which is crucial for tailoring treatment plans, managing symptoms more effectively, and providing genetic counseling for affected families.
The cost of the LGI1 Gene Epilepsy Familial Temporal Lobe Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the genetic analysis, the expertise required to interpret the results, and the potential life-changing impact that a precise diagnosis can have for patients and their families. It's an investment in understanding a genetic condition that affects not just the individual tested but can also have implications for their relatives, offering insights into inheritance patterns and risks for future generations.
The CPA6 gene epilepsy familial temporal lobe type 5 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the CPA6 gene, which are associated with familial temporal lobe epilepsy type 5. This condition is a form of epilepsy characterized by seizures originating in the temporal lobes of the brain, often accompanied by sensory disturbances, emotional changes, or other neurological impairments.
DNA Labs UAE offers this comprehensive genetic test to individuals who have a family history of temporal lobe epilepsy or exhibit symptoms associated with the condition. By analyzing the DNA sample, usually obtained through a blood draw, the test can determine the presence of specific genetic alterations in the CPA6 gene that are linked to the disorder. This information is crucial for accurate diagnosis, informed family planning, and personalized treatment strategies.
The cost of the CPA6 gene epilepsy familial temporal lobe type 5 genetic test at DNA Labs UAE is 4400 AED. This investment includes the collection of the sample, genetic sequencing, and a detailed report of the findings. The report not only provides insights into the individual's genetic predisposition to familial temporal lobe epilepsy type 5 but also offers guidance on potential management and treatment options based on the genetic makeup.
The RELN Gene Epilepsy Familial Temporal Lobe Type 7 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the RELN gene that are associated with Familial Temporal Lobe Epilepsy Type 7 (FTLE7). This condition is a form of epilepsy characterized by seizures originating in the temporal lobes of the brain, which can affect behavior, memory, and emotional control. The test aims to provide crucial genetic information that can aid in the precise diagnosis, management, and treatment planning for individuals and families affected by this condition. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and the detailed insights it offers into the genetic underpinnings of FTLE7. This test is particularly valuable for families with a history of temporal lobe epilepsy, offering them a clearer understanding of their genetic risk and potential preventive measures or targeted therapies.
The SCN3A gene plays a crucial role in the proper functioning of the brain's neurons. Mutations in this gene can lead to various neurological disorders, including a specific form of epilepsy known as focal SCN3A-related epilepsy. This condition is characterized by seizures that start in one area of the brain and can spread to other parts, potentially causing a range of symptoms from sensory disturbances to convulsions.
To diagnose this genetic condition accurately, DNA Labs UAE offers a specialized genetic test targeting the SCN3A gene. The test is designed to identify mutations in the SCN3A gene that are linked to the development of focal epilepsy. By analyzing a patient's DNA, the test can provide crucial information for the diagnosis, treatment planning, and management of the condition.
The cost of the SCN3A gene epilepsy focal SCN3A-related genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis necessary to detect the presence of SCN3A mutations. Early and accurate diagnosis through this test can significantly impact the management of the condition, allowing for targeted treatment strategies that can improve the quality of life for individuals affected by SCN3A-related epilepsy.
The HCN2 gene, also known as the hyperpolarization-activated cyclic nucleotide-gated potassium channel 2, plays a significant role in the electrical activity of the heart and brain. Mutations in this gene have been linked to various neurological conditions, including certain forms of epilepsy. Epilepsy associated with the HCN2 gene involves a spectrum of seizure disorders, which can vary in severity and response to treatment.
To aid in the diagnosis and management of epilepsy potentially linked to the HCN2 gene, DNA Labs UAE offers a specialized genetic test. This test is designed to identify mutations in the HCN2 gene that may contribute to the development of epilepsy. By pinpointing the specific genetic alterations, healthcare providers can gain valuable insights into the condition, allowing for a more personalized approach to treatment and management.
The test is conducted with a sample of the patient's DNA, typically collected through a blood draw or a cheek swab. The sample is then analyzed in the laboratory using advanced genetic sequencing techniques to detect any mutations in the HCN2 gene.
The cost of the HCN2 related genetic test at DNA Labs UAE is 4400 AED. This investment can be pivotal for individuals and families seeking answers to unexplained seizure disorders, as it not only provides a clearer diagnosis but also opens the door to targeted treatment options and a better understanding of the condition's prognosis.
